IHE Holdings — iShares U.S. Pharmaceuticals ETF
All 59 reported holdings of iShares U.S. Pharmaceuticals ETF (IHE) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Johnson & Johnson | 22.44% | $255.48M |
| Eli Lilly And Company | 22.25% | $253.23M |
| BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | 6.24% | $71.06M |
| Merck & Co., Inc. | 4.55% | $51.77M |
| Bristol-Myers Squibb Company | 4.37% | $49.73M |
| Royalty Pharma PLC | 4.33% | $49.35M |
| Viatris Inc. | 4.22% | $48.05M |
| Pfizer Inc. | 3.96% | $45.13M |
| Zoetis Inc. | 3.73% | $42.42M |
| Jazz Pharmaceuticals Public Limited Company | 3.45% | $39.28M |
| Elanco Animal Health Incorporated | 2.81% | $31.94M |
| Axsome Therapeutics, Inc. | 2.42% | $27.49M |
| Corcept Therapeutics Incorporated | 1.90% | $21.58M |
| Ligand Pharmaceuticals Incorporated | 1.45% | $16.46M |
| Definium Therapeutics Inc | 1.39% | $15.81M |
| Liquidia Corp | 1.28% | $14.55M |
| Indivior Pharmaceuticals, Inc. | 1.14% | $13.00M |
| Crinetics Pharmaceuticals Inc | 0.90% | $10.25M |
| Organon & Co. | 0.81% | $9.25M |
| Edgewise Therapeutics Inc | 0.70% | $7.96M |
| Amneal Pharmaceuticals, Inc. | 0.68% | $7.76M |
| Enliven Therapeutics Inc | 0.63% | $7.18M |
| Supernus Pharmaceuticals, Inc. | 0.62% | $7.02M |
| Tarsus Pharmaceuticals Inc | 0.57% | $6.47M |
| Veradermics Inc | 0.56% | $6.40M |
| Alumis Inc | 0.55% | $6.23M |
| Nektar Therapeutics | 0.54% | $6.13M |
| Prestige Consumer Healthcare Inc. | 0.51% | $5.81M |
| Trevi Therapeutics Inc | 0.50% | $5.72M |
| Ocular Therapeutix, Inc. | 0.39% | $4.47M |
| Innoviva, Inc. | 0.36% | $4.14M |
| Amylyx Pharmaceuticals Inc | 0.35% | $3.94M |
| Ani Pharmaceuticals, Inc. | 0.34% | $3.92M |
| MBX Biosciences Inc | 0.34% | $3.82M |
| Harmony Biosciences Holdings, Inc. | 0.33% | $3.78M |
| Perrigo Company Public Limited Company | 0.33% | $3.74M |
| Harrow, Inc. | 0.32% | $3.66M |
| Nuvation Bio Inc. | 0.32% | $3.60M |
| Xeris Biopharma Holdings, Inc. | 0.31% | $3.55M |
| Rapport Therapeutics Inc | 0.27% | $3.11M |
| Collegium Pharmaceutical, Inc. | 0.27% | $3.05M |
| Eyepoint, Inc. | 0.26% | $2.93M |
| AtaiBeckley Inc | 0.23% | $2.67M |
| Pacira Biosciences, Inc. | 0.23% | $2.59M |
| WAVE Life Sciences Ltd | 0.20% | $2.29M |
| Maze Therapeutics Inc | 0.19% | $2.18M |
| LB Pharmaceuticals Inc | 0.18% | $2.05M |
| BIOAGE Labs Inc | 0.18% | $2.03M |
| Septerna Inc | 0.18% | $2.00M |
| Amphastar Pharmaceuticals, Inc. | 0.16% | $1.79M |
| Omeros Corporation | 0.16% | $1.78M |
| Phibro Animal Health Corporation | 0.15% | $1.72M |
| Theravance Biopharma, Inc. | 0.15% | $1.67M |
| Cormedix Inc. | 0.13% | $1.49M |
| Phathom Pharmaceuticals, Inc. | 0.13% | $1.44M |
| Arvinas Inc | 0.12% | $1.40M |
| Evolus Inc | 0.10% | $1.19M |
| BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares | 0.07% | $808.36K |
| Xav Health Care Sep26 | 0.00% | $26.72K |